ABL, an Institut Mérieux Company

ABL is a pure play Contract Development and Manufacturing Organization (CDMO) specialized in the development and manufacturing of virus for vaccine candidates, gene and cancer therapies. ABL's mission is to provide GMP viral vectors from early-stage to market, contributing to the success of its  clients' immunotherapy innovations. ABL's CDMO services include bulk drug substance, fill/finish of drug products, process and assay development, and bioanalytical testing.

ABL is a subsidiary of the Institut Mérieux and operates from various locations in Europe and the US.